Study Details

General Information

Shionogi Obesity 2201N1121

A Phase 2, multicenter, randomized, double-blind, dose-ranging, placebo-controlled study to assess the safety and efficacy of S-309309 in obese adults.

Protocol2201N1121
Identifier
UIDb322df97-9a33-48d7-b37e-637abe20394c
StatusDone - Archived
Phase2
CategoryObesity / Adult
Launch Year0
NCT Number-
Created2023-05-10 09:58
Last Updated2024-08-12 20:47

Description

No description provided.

Comment

No comment.

Target Dates

NameDateRequired
Enrollment Closed2023-10-19No
Enrollment Open2023-07-17No
First Patient First VisitNo
Site Initiation Mtg.2023-06-27No
PI Meeting StartNo
PI Meeting EndNo
PI Meeting ArrivalNo
PI Meeting DepartureNo
Closeout Date2024-06-11No
Final PatientVisitNo
PreStudy Selection VisitNo
Target Date 12No
Target Date 13No
Target Date 14No

Leadership

RoleStaffLoginRequired
PrincipalMohseni, RizwanaRMohseniNo
RecruiterGomez, KathieKGomezNo
CoordinatorArmendariz, RocioRArmendarizNo
RegulatoryRamirez, ClaudiaCRamirezNo

Custom Fields

No custom fields.

Sponsor & Organization

SponsorShionogi
DivisionShionogi
TeamShionogi
Managing SiteCatalina Research Institute, LLC
Organization

Contacts

IRB Ref
CROPPD Investigator Services, LLC
CRO Ref
Correspondence0

Opportunity

Probability0
Comment
Status ColorGainsboro
Currency-
Mayra Sibley

2 Hours

Hi there, I'm Jesse and you?
You

3 minutes

My name is Anne Clarc.
Mayra Sibley

40 seconds

Nice to meet you Anne.
How can i help you?